CPF III-A PT SPV, LLC 的 Form 4/A 修正申報
修正P3 Health Partners Inc.（PIII），2023/10/4 申報
- 申報編號
- 0001062993-23-018941
- 申報時間
- 2023/10/4 08:18 ET
- 交易日
- 2023/9/11-9/13
- 申報延遲
- 23 天
- 10b5-1 計畫
- 沒有勾選
- 原始申報日
- 2023/9/13
這份申報列了 3 筆非衍生性交易。公開市場買進合計 $68.5 萬。交易後 23 天申報。
這份申報後來被修正申報 0001213900-24-077451（2024/9/10）取代，網站的交易表改用修正後的版本。
這份修正申報取代了 0001062993-23-017986（2023/9/13 申報）。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| CPF III-A PT SPV, LLCCIK 0001975600 | 持股 10% 以上大股東 |
| CPF III PT SPV, LLCCIK 0001975601 | 持股 10% 以上大股東 |
| Chicago Pacific Founders UGP III, LLCCIK 0001975658 | 持股 10% 以上大股東 |
| Chicago Pacific Founders GP III, L.P.CIK 0001975828 | 持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
Includes (i) 69,433.68 shares of Common Stock directly acquired by CPF III PT SPV, LLC ("SPV III") and (ii) 20,566.32 shares of Common Stock directly acquired by CPF III PT SPV-A, LLC ("SPV-A III").
- F2
The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.20 to $2.40, inclusive. The reporting persons undertake to provide to P3 Health Partners Inc., any security holder of P3 Health Partners Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 2.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Chicago Pacific Founders UGP, III LLC ("UGP III") is the general partner of Chicago Founders GP III, LP ("GP III"), the general partner of each of SPV III and SPV III-A. As a result, UGP III has the power to vote and dispose of the Issuer's securities held by SPV III and SPV III-A (the "Underlying Securities"). Each of UGP III and GP III disclaims beneficial ownership for the amount in excess of their pecuniary interest in the Underlying Securities.
- F4
The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.36 to $2.9366, inclusive. The reporting persons undertake to provide to P3 Health Partners Inc., any security holder of P3 Health Partners Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 4.
表 I 有 1 筆交易的價格引用這則附註。
- F5
The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.52 to $2.84, inclusive. The reporting persons undertake to provide to P3 Health Partners Inc., any security holder of P3 Health Partners Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 5.
表 I 有 1 筆交易的價格引用這則附註。
備註
This amended Form 4 is filed to correct the number of shares of Class A Common Stock owned by the reporting persons due to a reporting error which first occurred in the Form 4 filed by the reporting persons on August 30, 2023.